OMIC Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.

$11.48  -0.03 (-0.26%)
As of 11/30/2021 15:59:55 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  05/27/2021
Outstanding shares:  72,058,523
Average volume:  288,174
Market cap:   $912,260,901
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    82933R100
ISIN:        US82933R1005
Sedol:      BLB0YL4

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   2.35
PS ratio:   0.00
Return on equity:   -24.69%
Net income %:   0.00%